Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus Ribavirin

Background. Direct-acting antiviral agents against HCV with or without peginterferon plus ribavirin result in higher eradication rates of HCV and shorter treatment duration. We examined which is better for predicting persistent virologic response, the assessment of serum HCV RNA at 12 or 24 weeks af...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Int J Med Sci
Hoofdauteurs: Kanda, Tatsuo, Nakamoto, Shingo, Sasaki, Reina, Nakamura, Masato, Yasui, Shin, Haga, Yuki, Ogasawara, Sadahisa, Tawada, Akinobu, Arai, Makoto, Mikami, Shigeru, Imazeki, Fumio, Yokosuka, Osamu
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Ivyspring International Publisher 2016
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4829545/
https://ncbi.nlm.nih.gov/pubmed/27076789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.14953
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items